Medicine and Dentistry
Peroxisome Proliferator Activated Receptor
100%
Carboxylase
83%
Acetyl-CoA
83%
Combination Therapy
33%
Diseases
16%
Metabolic Syndrome
16%
Obesity
16%
Lipid
16%
Lipogenesis
16%
Therapeutic Agent
16%
Screening
16%
Maturity Onset Diabetes of the Young
16%
Dyslipidemia
16%
Peroxisome Proliferator Activated Receptor Agonist
16%
Acetyl Coenzyme A Carboxylase Inhibitor
16%
Therapeutic Procedure
16%
Pharmacology, Toxicology and Pharmaceutical Science
Peroxisome Proliferator Activated Receptor
100%
Carboxylase
83%
Acetyl-CoA
83%
Acetamide Derivative
50%
Diseases
16%
Lipid
16%
Non Insulin Dependent Diabetes Mellitus
16%
Dyslipidemia
16%
Obesity
16%
PPAR Agonist
16%
Metabolic Syndrome X
16%
Acetyl Coenzyme A Carboxylase Inhibitor
16%
Chemistry
Peroxisome Proliferator
100%
Acetyl-CoA
100%
Acetamide
50%
Inhibitor
50%
Ethyl
33%
Metabolic
16%
Lipid
16%
Modulator
16%
Peroxisome Proliferator Activated Receptor Agonist
16%
Biochemistry, Genetics and Molecular Biology
Peroxisome Proliferator-Activated Receptor
100%
Acetyl-CoA Carboxylase
100%
Screening
16%
Lipogenesis
16%
Dyslipidemia
16%
Neuroscience
Peroxisome Proliferator-Activated Receptor
100%
Acetamide
50%
Lipid
16%
Diabetes Mellitus
16%
PPAR Agonist
16%
Dyslipidemia
16%